| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3847692 | American Journal of Kidney Diseases | 2014 | 9 Pages |
Abstract
Contrary to our expectation, we found that atenolol versus metoprolol tartrate was associated with lower 90-day risk of mortality in patients regardless of eGFR, with no difference in risk of hospitalization with bradycardia or hypotension.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Jamie L. BHSc, Matthew A. MD, Eric MSc, Sundus MD, Philip J. MD, PhD, Matthew A. MD, Arsh K. MD, Amit X. MD, PhD,